Coronary Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021
This Medical Devices sector report, “Coronary Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The report enables you to -
Summary
This Medical Devices sector report, “Coronary Stents (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Coronary Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Coronary Stents - Pipeline Products under Development by Companies
5 Coronary Stents Companies and Product Overview
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Vascular Inc
- Adcomp Technologies Inc.
- Advanced Bifurcation Systems Inc
- Aeon Bioscience
- AlviMedica Medical Technologies Inc
- Amaranth Medical Inc
- Atrium Medical Corp
- Axordia Ltd (Inactive)
- B. Braun Melsungen AG
- Bactiguard Holding AB
- Bionext Biotech Products Ltd.
- Biosensors International Group Ltd
- Biosten, LLC
- Biotronik AG
- Biotronik SE & Co KG
- Biotyx Medical
- Boston Scientific Corp
- Cardionovum GmbH
- Cardiorev Pte Ltd (Inactive)
- Columbia University
- Concept Medical Inc
- Contego Medical LLC
- Cordis Corp
- Cytograft Tissue Engineering Inc (Inactive)
- DISA Vascular (Pty) Ltd
- Elixir Medical Corp
- Envision Scientific Pvt Ltd
- HangZhou HuaAn Biotechnology Co., Ltd.
- I.B.S. S.p.A.
- Icon Interventional Systems, Inc.
- ID Nest Medical SAS
- InspireMD Inc
- Japan Stent Technology Co., Ltd.
- JW Medical Systems Ltd
- Kaneka Corp
- Kyoto Medical Planning Co Ltd
- Liaoning Biomedical Materials R&D Center Co Ltd
- Lifetech Scientific (Shenzhen) Co Ltd
- MangoGen Pharma Inc
- Manli Cardiology Ltd
- Medinol Ltd
- Medlogics Device Corp (Inactive)
- Medtronic Plc
- Meril Life Sciences Pvt Ltd
- Miami Cardiovascular Innovations
- Micell Technologies Inc
- Michigan Technological University
- MicroPort Scientific Corp
- Minvasys SAS
- MIV Therapeutics Inc
- NanoCoeur, Inc.
- Nanova, Inc
- National University of Ireland Galway
- Nesstent Ltd.
- Nexeon MedSystems Inc
- North Carolina State University
- Northwestern University
- NuVascular Technologies Inc
- OrbusNeich
- Palmaz Scientific Inc (Inactive)
- Pediastent LLC
- QualiMed Innovative Medizinprodukte GmbH
- Qvanteq AG
- Relisys Medical Devices Ltd
- REVA Medical Inc
- Rontis AG
- S3V Vascular Technologies
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Sino Medical Sciences Technology Inc
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- Stentys SA
- Svelte Medical Systems Inc
- Tepha Inc
- Terumo Corp
- Terumo Interventional Systems
- TissueGen Inc
- Tremedics Medical Devices LLC
- TrendyMED Inc.
- University of Alabama at Birmingham
- University of Colorado
- University of Florida
- University of Michigan
- University of Strathclyde
- University of Utah
- VasoTech Inc.
- Viller Scientific LLC
- Vornia Biomaterials Ltd
- Xenogenics Corporation
